Search research articles
Contact Us
Filters
Showing results (291-300 of 315) with videos related to
Page
of 32
Sort By:
Cancer Cell
|
November 16, 2005
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein
Paolo Neviani, Ramasamy Santhanam, Rossana Trotta, et al.
Blood
|
March 31, 2009
TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia
Jianhua Yu, Maxim Ershler, Li Yu, et al.
The Journal of Clinical Investigation
|
March 3, 2011
NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human
Jianhua Yu, Takeki Mitsui, Min Wei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2007
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia
William Blum, Rebecca B Klisovic, Bjoern Hackanson, et al.
The Journal of Clinical Investigation
|
September 19, 2006
Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations
Adrienne M Dorrance, Shujun Liu, Weifeng Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2008
A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemia
Rebecca B Klisovic, Wendy Stock, Spero Cataland, et al.
Cell Death & Disease
|
November 7, 2025
The RNA N<sup>6</sup>-methyladenosine methylome coordinates long non-coding RNAs to mediate cancer drug resistance by activating PI3K signaling
Yanhong Tan, Changli Zhou, Sicheng Bian, et al.
Blood
|
December 18, 2007
Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia
Shujun Liu, Zhongfa Liu, Zhiliang Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2010
Dose escalation of lenalidomide in relapsed or refractory acute leukemias
William Blum, Rebecca B Klisovic, Heiko Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2005
Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity
Guido Marcucci, Wendy Stock, Guowei Dai, et al.
Page
of 32
Search research articles
Search
Showing results (291-300 of 315) with videos related to
Sort By:
Page
of 32
Cancer Cell
|
November 16, 2005
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein
Paolo Neviani, Ramasamy Santhanam, Rossana Trotta, et al.
Blood
|
March 31, 2009
TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia
Jianhua Yu, Maxim Ershler, Li Yu, et al.
The Journal of Clinical Investigation
|
March 3, 2011
NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human
Jianhua Yu, Takeki Mitsui, Min Wei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2007
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia
William Blum, Rebecca B Klisovic, Bjoern Hackanson, et al.
The Journal of Clinical Investigation
|
September 19, 2006
Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations
Adrienne M Dorrance, Shujun Liu, Weifeng Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2008
A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemia
Rebecca B Klisovic, Wendy Stock, Spero Cataland, et al.
Cell Death & Disease
|
November 7, 2025
The RNA N<sup>6</sup>-methyladenosine methylome coordinates long non-coding RNAs to mediate cancer drug resistance by activating PI3K signaling
Yanhong Tan, Changli Zhou, Sicheng Bian, et al.
Blood
|
December 18, 2007
Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia
Shujun Liu, Zhongfa Liu, Zhiliang Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2010
Dose escalation of lenalidomide in relapsed or refractory acute leukemias
William Blum, Rebecca B Klisovic, Heiko Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2005
Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity
Guido Marcucci, Wendy Stock, Guowei Dai, et al.
Page
of 32